Suppr超能文献

相似文献

1
Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs.
Free Radic Biol Med. 2010 Jun 1;48(11):1559-63. doi: 10.1016/j.freeradbiomed.2010.03.001. Epub 2010 Mar 6.
2
Redox properties and thiol reactivity of geldanamycin and its analogues in aqueous solutions.
J Phys Chem B. 2012 Jun 7;116(22):6404-10. doi: 10.1021/jp304206n. Epub 2012 May 25.
3
One-electron reduction of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: a pulse radiolysis study.
J Phys Chem A. 2011 Aug 18;115(32):8928-32. doi: 10.1021/jp205161v. Epub 2011 Jul 22.
4
HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis.
Cardiovasc Res. 2012 Jul 1;95(1):116-23. doi: 10.1093/cvr/cvs158. Epub 2012 Apr 30.
6
Oxidative stress plays a critical role in inactivating mutant BRAF by geldanamycin derivatives.
Cancer Res. 2008 Aug 1;68(15):6324-30. doi: 10.1158/0008-5472.CAN-07-6602.
7
17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2348-56. doi: 10.1167/iovs.07-1305. Epub 2008 Feb 15.
8
Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives.
Expert Opin Ther Pat. 2013 Aug;23(8):919-43. doi: 10.1517/13543776.2013.780597. Epub 2013 May 4.
9
Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells.
Cancer Lett. 2009 Oct 18;284(1):62-70. doi: 10.1016/j.canlet.2009.04.012. Epub 2009 May 21.
10
Synthesis and biological evaluation of geldanamycin analogs against human cancer cells.
Cancer Chemother Pharmacol. 2015 Apr;75(4):773-82. doi: 10.1007/s00280-015-2696-9. Epub 2015 Feb 14.

引用本文的文献

1
Hsp90 and Isoform-Selective Inhibitors as Sensitizers for Cancer Immunotherapy.
Pharmaceuticals (Basel). 2025 Jul 10;18(7):1025. doi: 10.3390/ph18071025.
3
The role of heat shock protein 90 in idiopathic pulmonary fibrosis: state of the art.
Eur Respir Rev. 2025 Mar 19;34(175). doi: 10.1183/16000617.0147-2024. Print 2025 Jan.
5
Hsp90 inhibition leads to an increase in surface expression of multiple immunological receptors in cancer cells.
Front Mol Biosci. 2024 Apr 5;11:1334876. doi: 10.3389/fmolb.2024.1334876. eCollection 2024.
7
The chaperone system in cancer therapies: Hsp90.
J Mol Histol. 2023 Apr;54(2):105-118. doi: 10.1007/s10735-023-10119-8. Epub 2023 Mar 18.
8
HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review).
Oncol Rep. 2023 Jan;49(1). doi: 10.3892/or.2022.8443. Epub 2022 Nov 11.
10
Heat Shock Proteins and HSF1 in Cancer.
Front Oncol. 2022 Mar 2;12:860320. doi: 10.3389/fonc.2022.860320. eCollection 2022.

本文引用的文献

2
Flavin-dependent quinone reductases.
Cell Mol Life Sci. 2008 Jan;65(1):141-60. doi: 10.1007/s00018-007-7300-y.
4
Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein.
J Mol Med (Berl). 2006 Aug;84(8):635-46. doi: 10.1007/s00109-006-0066-0. Epub 2006 Jun 2.
8
Chemistry of peroxynitrites as compared to peroxynitrates.
Chem Rev. 2005 Jun;105(6):2457-70. doi: 10.1021/cr0307087.
9
Population pharmacokinetic analysis of 17-(allylamino)-17-demethoxygeldanamycin (17AAG) in adult patients with advanced malignancies.
Cancer Chemother Pharmacol. 2005 Mar;55(3):237-43. doi: 10.1007/s00280-004-0836-8. Epub 2004 Oct 19.
10
Nitric oxide, oxidants, and protein tyrosine nitration.
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4003-8. doi: 10.1073/pnas.0307446101. Epub 2004 Mar 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验